flutrimazole 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
1227 119006-77-8

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • UR-4056
  • flutrimazole
  • Molecular weight: 346.38
  • Formula: C22H16F2N2
  • CLOGP: 4.58
  • LIPINSKI: 0
  • HAC: 2
  • HDO: 0
  • TPSA: 17.82
  • ALOGS: -5.59
  • ROTB: 4

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 4.905 Moderate 0.66
caco2-efflux Caco-2 efflux ratio (BA/AB) 3.758 Moderate 0.66
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 10.280 10^-6 cm/s Moderate 0.66
dh-clint Dog hepatocyte intrinsic clearance 14.757 uL/min/10^6 cells Moderate 0.66
dppb Dog plasma protein binding (% unbound) 0.070 % Moderate 0.66
fcs-ppb Fetal calf serum protein binding (% unbound) 0.530 % Moderate 0.66
herg hERG pIC50 5.624 pIC50 Moderate 0.66
hh-clint Human hepatocyte intrinsic clearance 25.235 uL/min/10^6 cells Moderate 0.66
hlm-clint Human liver microsomal intrinsic clearance 44.668 uL/min/mg protein Moderate 0.66
hppb Human plasma protein binding (% unbound) 0.170 % Moderate 0.66
kinase-safety-class ACVR2B,AXL,CDK5,EIF2AK3,GRK2,ITK,MAPK10,MAPKAPK2,PDK2,PDK4 10
kinase-selectivity-class AXL,ERBB2,GRK2,MAP2K6,PDK4 5
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 9.484 Moderate 0.66
mh-clint Mouse hepatocyte intrinsic clearance 51.761 Moderate 0.66
mppb Mouse plasma protein binding (% unbound) 0.210 Moderate 0.66
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 17.219 Moderate 0.66
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pld-class Phospholipidosis risk class (1 = positive, 0 = negative) 1 Moderate 0.66
pppb Pig plasma protein binding (% unbound) 0.330 % Moderate 0.66
rh-clint Rat hepatocyte intrinsic clearance 55.719 uL/min/10^6 cells Moderate 0.66
rh-fuinc Rat hepatocyte fraction unbound in incubation 0.440 % Moderate 0.66
rppb Rat plasma protein binding (% unbound) 0.210 % Moderate 0.66
solubility-dd Solubility at pH 7.4 in DMSO 10.715 uM Moderate 0.66

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC D01AC16 DERMATOLOGICALS
ANTIFUNGALS FOR DERMATOLOGICAL USE
ANTIFUNGALS FOR TOPICAL USE
Imidazole and triazole derivatives
ATC G01AF18 GENITO URINARY SYSTEM AND SEX HORMONES
GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
Imidazole derivatives
MeSH PA D000890 Anti-Infective Agents
MeSH PA D000935 Antifungal Agents
CHEBI has role CHEBI:77884 EC 1.14.13.70 (sterol 14α-demethylase) inhibitor

Related Drugs by ATC class:

D01AC Imidazole and triazole derivatives 20 drugs
bifonazolechlormidazoleclotrimazoleeberconazoleeconazoleefinaconazolefenticonazolefluconazoleisoconazoleketoconazolelanoconazoleluliconazole show all 20 →
G01AF Imidazole derivatives 16 drugs
azanidazolebutoconazoleclotrimazoleeconazolefenticonazoleisoconazoleketoconazolemetronidazolemiconazoleomoconazoleornidazoleoxiconazole show all 16 →

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 6.21 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
Nuclear receptor subfamily 1 group I member 2 Nuclear hormone receptor EC50 5.21 CHEMBL
Bile acid receptor Nuclear hormone receptor IC50 4.86 CHEMBL

External reference:

IDSource
D07193 KEGG_DRUG
C0172907 UMLSCUI
CHEBI:82864 CHEBI
CHEMBL2107430 ChEMBL_ID
DB13425 DRUGBANK_ID
C076986 MESH_SUPPLEMENTAL_RECORD_UI
3401 PUBCHEM_CID
6460 INN_ID
776S0UP252 UNII
61773 RXNORM
009433 NDDF
697966001 SNOMEDCT_US
776S0UP252 INXIGHT DRUGS

Pharmaceutical products:

None